Short answer
Stryker Corporation (SYK) filed an 8-K current report with the SEC on October 29, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Third-quarter 2026 operating results announced October 29, 2026.
Stryker Corporation 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Third-quarter 2026 operating results announced October 29, 2026
- Detailed financial results and management commentary contained in Exhibit 99.1
- Exhibit information furnished under Regulation FD, not deemed filed under Section 18 of the Exchange Act
Item EX-99.1 · Exhibit EX-99.1
- Q3 net sales $6.5B, up 7.7%, with organic growth entirely volume-driven
- MedSurg and Neurotechnology growth 9.1%, outperforming Orthopaedics at 5.9%
- Adjusted EPS $3.52, up 10.3%, and adjusted operating margin 26.2%, up 60 basis points
- Reported EPS fell 11.7% to $1.96, pressured by $293M goodwill impairment and other special charges
- 2026 guidance reset: organic sales growth 6.5%-7.0%, adjusted EPS $14.80-$14.90, plus $3.0B added buyback authorization
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Stryker Corporation 8-K filings
Get the next SYK 8-K as it lands
Follow SYK for push alerts, or ask the research agent what this filing means.